Drugs / Lactated Ringer's solution
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00431743 | Apr → Sep 2009 | — | Rigshospitalet, Denmark | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactated Ringer's solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00431743 ↗ |
| Modality | Other / unclassified | “using a colloid (HES 130/0,4) will improve orthostatic function, nausea/vomiting and shorten hospital stay, compared to using a crystalloid (Lactated Ringer's solution).” NCT00431743 ↗ |